Invus Global Management, LLC - Jun 30, 2025 SCHEDULE 13G/A Report for Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share (BCAX)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Bicara Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol
BCAX
Shares outstanding
54.3M shares
Disclosed Ownership
5.22M shares
Ownership
9.6%
Form type
SCHEDULE 13G/A
Date filed
7/31/2025, 02:56 PM
Date of event
Jun 30, 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.9% 4.86M 4.86M 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.9% 4.86M 4.86M 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.9% 4.86M 4.86M 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.9% 4.86M 4.86M 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 0.7% 355K 355K 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 0.7% 355K 355K 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 0.7% 355K 355K 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 9.6% 5.22M 5.22M 0 /s/ Raymond Debbane Raymond Debbane